SCHEMBL7701869

SCHEMBL7701869

Bc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1

nearest known ligand 0.78

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KDR P35968 8/20 0.78
CHEK1 O14757 8/20 0.72
CDK1 P06493 1/20 0.72
CDK2 P24941 1/20 0.72
PDGFRB P09619 2/20 0.50
NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7701873 0.88 KDR (0.60) KDRCHEK1CDK1CDK2PDGFRB
SCHEMBL29819445 0.88 KDR (1.00) KDRCHEK1CDK1CDK2PDGFRB
SCHEMBL6968182 0.88 KDR (1.00) KDRCHEK1CDK1CDK2PDGFRB
SCHEMBL7089495 0.85 KDR (0.78) KDRCHEK1CDK1CDK2PDGFRB
SCHEMBL6967709 0.85 KDR (0.78) KDRCHEK1CDK1CDK2PDGFRB
SCHEMBL7002715 0.85 KDR (0.78) KDRCHEK1CDK1CDK2PDGFRB
SCHEMBL6958584 0.85 KDR (0.78) KDRCHEK1CDK1CDK2PDGFRB
SCHEMBL11865835 0.85 KDR (0.78) KDRCHEK1CDK1CDK2PDGFRB
SCHEMBL7000053 0.85 CHEK1 (0.97) KDRCHEK1CDK1CDK2
SCHEMBL4810393 0.84 CHEK1 (1.00) KDRCHEK1CDK1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed